49643-104 : Botrytis 1 g/10ml Cutaneous; Intradermal; Subcutaneous Injection
NDC: | 49643-104 |
Labeler: | Allermed Laboratories, Inc. |
Product Type: | Non-standardized Allergenic |
Drug Name: | Botrytis |
Dosage Form: | Cutaneous; Intradermal; Subcutaneous Injection |
Application #: | BLA102212 |
Rev. Date: |
NDC Package Codes:
- 49643-104-05: 5 ML IN 1 VIAL, MULTI‑DOSE (49643‑104‑05)
- 49643-104-10: 10 ML IN 1 VIAL, MULTI‑DOSE (49643‑104‑10)
- 49643-104-30: 30 ML IN 1 VIAL, MULTI‑DOSE (49643‑104‑30)
- 49643-104-50: 50 ML IN 1 VIAL, MULTI‑DOSE (49643‑104‑50)
Active Ingredients:
- Botrytis Cinerea
Dosage Strength:
- .1 g/mL
Pharmaceutical Classes:
- Allergens [CS]
- Cell-mediated Immunity [PE]
- Fungal Proteins [CS]
- Increased Histamine Release [PE]
- Increased IgG Production [PE]
- Non-Standardized Fungal Allergenic Extract [EPC]
Related Products:
Based on records with the same trade name.- 49288-0038 Botrytis .1 g/ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
- 49288-0039 Botrytis .05 g/ml Intradermal; Subcutaneous Injection, Solution by Antigen Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 49643-101Next: 49643-105 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.